Analysis of the Case of Second Medical Use Patent: Actavis UK Ltd V Merck & Co Inc.
Second (Further) Medical Use patents is an essential component of the potential second-line patent protection. It is among many issues faced in the pharmaceutical industry. Apart from the loss of income, the originators face difficulties in relation to securing secondary patents. These patents would facilitate...